Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1022899/000149315224012333/form10-k.htm
SEC Filings
PTIX Annual Reports
PTIX Quarterly Reports
10-Q Quarterly Report November 2023
10-Q Quarterly Report August 2023
10-Q Quarterly Report May 2023
10-Q Quarterly Report November 2022
10-Q Quarterly Report August 2022
10-Q Quarterly Report May 2022
10-Q Quarterly Report November 2021
10-Q Quarterly Report August 2021
10-Q Quarterly Report May 2021
10-Q Quarterly Report November 2020
10-Q Quarterly Report November 2023
10-Q Quarterly Report August 2023
10-Q Quarterly Report May 2023
10-Q Quarterly Report November 2022
10-Q Quarterly Report August 2022
10-Q Quarterly Report May 2022
10-Q Quarterly Report November 2021
10-Q Quarterly Report August 2021
10-Q Quarterly Report May 2021
10-Q Quarterly Report November 2020
PTIX Corporate News
Financial Exhibit
Other Events
Regulated Disclosure March 2024
Vote of Security Holders December 2023
Listing Status November 2023
Bylaw Change
Financial Exhibit
Regulated Disclosure March 2023
Other Events
Vote of Security Holders November 2022
Other Events September 2022
Other Events June 2022
Listing Status October 2021
Bylaw Change
Financial Exhibit
Vote of Security Holders October 2021
Financial Exhibit
Other Events
Regulated Disclosure August 2021
Financial Exhibit
Other Events
Regulated Disclosure
Other Events
Regulated Disclosure
March 2024
Vote of Security Holders
December 2023
Listing Status
November 2023
Bylaw Change
Financial Exhibit
Regulated Disclosure
Financial Exhibit
Regulated Disclosure
March 2023
Other Events
Vote of Security Holders
Vote of Security Holders
November 2022
Other Events
September 2022
Other Events
June 2022
Listing Status
October 2021
Bylaw Change
Financial Exhibit
Vote of Security Holders
Financial Exhibit
Vote of Security Holders
October 2021
Financial Exhibit
Other Events
Regulated Disclosure
Other Events
Regulated Disclosure
August 2021
PTIX Corporate News
PTIX Registration of Securities
Last10K.com | 10-K Annual Report Mon Apr 01 2024
Cover - USD ($) | 12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2023 | Mar. 29, 2024 | Jun. 30, 2023 | |
| Document Type | 10-K | ||
| Amendment Flag | false | ||
| Document Annual Report | true | ||
| Document Transition Report | false | ||
| Document Period End Date | Dec. 31, 2023 | ||
| Document Fiscal Period Focus | FY | ||
| Document Fiscal Year Focus | 2023 | ||
| Current Fiscal Year End Date | --12-31 | ||
| Entity File Number | 001-12555 | ||
| Entity Registrant Name | Protagenic Therapeutics, Inc.\new | ||
| Entity Central Index Key | 0001022899 | ||
| Entity Tax Identification Number | 06-1390025 | ||
| Entity Incorporation, State or Country Code | DE | ||
| Entity Address, Address Line One | 149 Fifth Avenue | ||
| Entity Address, City or Town | New York | ||
| Entity Address, State or Province | NY | ||
| Entity Address, Postal Zip Code | 10010 | ||
| City Area Code | (212) | ||
| Local Phone Number | 994-8200 | ||
| Entity Well-known Seasoned Issuer | No | ||
| Entity Voluntary Filers | No | ||
| Entity Current Reporting Status | Yes | ||
| Entity Interactive Data Current | Yes | ||
| Entity Filer Category | Non-accelerated Filer | ||
| Entity Small Business | true | ||
| Entity Emerging Growth Company | false | ||
| Entity Shell Company | false | ||
| Entity Public Float | $ 8,791,847 | ||
| Entity Common Stock, Shares Outstanding | 4,435,132 | ||
| Documents Incorporated by Reference | None | ||
| ICFR Auditor Attestation Flag | false | ||
| Document Financial Statement Error Correction [Flag] | true | ||
| Document Financial Statement Restatement Recovery Analysis [Flag] | true | ||
| Auditor Firm ID | 206 | ||
| Auditor Name | MaloneBailey, LLP | ||
| Auditor Location | Houston, Texas | ||
| Common Stock [Member] | |||
| Title of 12(b) Security | Common Stock, par value $0.0001 | ||
| Trading Symbol | PTIX | ||
| Security Exchange Name | NASDAQ | ||
| Common Stock Purchase Warrant [Member] | |||
| Title of 12(b) Security | Common Stock Purchase Warrant | ||
| Trading Symbol | PTIXW | ||
| Security Exchange Name | NASDAQ |
View differences made from one year to another to evaluate Protagenic Therapeutics, Inc.New's financial trajectory
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Protagenic Therapeutics, Inc.New.
Assess how Protagenic Therapeutics, Inc.New's management team is paid from their Annual Proxy
Protagenic Therapeutics, Inc.New's Definitive Proxy Statement (Form DEF 14A) filed after their 2024 10-K Annual Report includes:
- Voting Procedures
- Board Members
- Executive Team
- Salaries, Bonuses, Perks
- Peers / Competitors
SEC Filing Tools
Financial Statements, Disclosures and Schedules
Inside this 10-K Annual Report
Cover
Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Change In Stockholders' Equity
Consolidated Statements Of Operations And Comprehensive Loss
Accounts Payable And Accrued Expenses
Accounts Payable And Accrued Expenses (Tables)
Collaborative Agreements
Collaborative Agreements (Details Narrative)
Commitments And Contingencies
Commitments And Contingencies (Details Narrative)
Income Taxes
Income Taxes (Details Narrative)
Income Taxes (Tables)
Insider Trading Arrangements
Liquidity And Going Concern
Note Payable And Convertible Note Payable (Pik Notes)
Note Payable And Convertible Note Payable (Pik Notes) (Details Narrative)
Organization And Nature Of Business
Organization And Nature Of Business (Details Narrative)
Pay Vs Performance Disclosure
Related Party Transactions
Related Party Transactions (Details Narrative)
Schedule Of Accounts Payable And Accrued Expenses (Details)
Schedule Of Anti-Dilutive Securities Excluded From Computation Of Earnings Per Share (Details)
Schedule Of Deferred Tax Assets And Liabilities (Details)
Schedule Of Effective Income Tax Rate Reconciliation (Details)
Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basic (Details)
Schedule Of Loss Before Income Tax (Details)
Schedule Of Share-Based Compensation Nonvested Shares (Details)
Schedule Of Share-Based Compensation, Stock Options, Activity (Details)
Schedule Of Share-Based Payment Award, Stock Options, Valuation Assumptions (Details)
Stockholders??? Equity
Stockholders??? Equity (Details Narrative)
Stockholders??? Equity (Tables)
Subsequent Events
Subsequent Events (Details Narrative)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Details Narrative)
Summary Of Significant Accounting Policies (Policies)
Summary Of Significant Accounting Policies (Tables)
Summary Of Warrant (Details)
Material Contracts, Statements, Certifications & more
Protagenic Therapeutics, Inc.New provided additional information to their SEC Filing as exhibits
Exhibit 4.1: Instruments Defining The Rights Of Security Holders, Including Indentures
Exhibit 21.1: Subsidaries Of The Registrant
Exhibit 31.1: Rule 13A-14(A)/15D-14(A) Certification
Exhibit 31.2: Rule 13A-14(A)/15D-14(A) Certification
Exhibit 97.1:
Exhibit 99.1: Additional Exhibits
Exhibit 99.2: Additional Exhibits
Exhibit 99.3: Additional Exhibits
Ticker: PTIX
CIK: 1022899
Form Type: 10-K Annual Report
Accession Number: 0001493152-24-012333
Submitted to the SEC: Mon Apr 01 2024 4:00:54 PM EST
Accepted by the SEC: Mon Apr 01 2024
Period: Sunday, December 31, 2023
Industry: Business Services
External Resources:
Stock Quote
Social Media
SEC.gov
Bookmark the Permalink: https://last10k.com/sec-filings/ptix/0001493152-24-012333.htm
SEC Filing Exhibit
PDF Download
Loading SEC Filing Exhibit...
Excel DownloadLoading SEC Filing Financial Summary...